Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bridging Inflammation and Oncology: The Role and Therapeutic Potential of Macrophage Migration Inhibitory Factor in Lung Cancer.

International journal of molecular sciences - 20 Mar 2026

Selo Mohammed Ali, Gobbo Oliviero L, Obaidi Ismael, O'Connor Christine, Fayne Darren, Armstrong Michelle E, Donnelly Seamas C

Abstract excerpt

Lung cancer is the leading cause of cancer-related mortality worldwide, accounting for more deaths than any other malignancy. Despite advances in treatment, it remains highly lethal, with 5-year survival rates showing minimal improvement over the past several decades, highlighting a critical unmet clinical need. Macrophage Migration Inhibitory Factor (MIF) is a multifunctional cytokine that contributes to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to MIF gene
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammation

Share to Intramolecular Oxidoreductases

Share to Lung Neoplasms

Share to Macrophage Migration-Inhibitory Factors

Share to Polymorphism, Genetic

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 41898690
DOI: 10.3390/ijms27062829
PMCID: PMC13026153

Genes

MIF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bridging Inflammation and Oncology: The Role and Therapeutic Potential of Macrophage Migration Inhibitory Factor in Lung Cancer.PMID 41898690Read ↗

Bridging Inflammation and Oncology: The Role and Therapeutic Potential of Macrophage Migration Inhibitory Factor in Lung CancerSemantic proximity Read ↗

Macrophages, Inflammation, and Lung Cancer.Semantic proximity Read ↗

Insights Into Lung Cancer Immune-Based Biology, Prevention, and Treatment.Semantic proximity Read ↗

Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to TalkSemantic proximity Read ↗

The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung CancerSemantic proximity Read ↗

Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte FunctionSemantic proximity Read ↗

Implications of MDSCs-targeting in lung cancer chemo-immunotherapeutics.Semantic proximity Read ↗

Shaping the battlefield: EGFR and KRAS tumor mutations' role on the immune microenvironment and immunotherapy responses in lung cancer.Semantic proximity Read ↗

Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axisSemantic proximity Read ↗

Macrophage inhibitory cytokine-1 in cancer: Beyond the cellular phenotype.Semantic proximity Read ↗

Tumor Microenvironment Properties are Associated With Low CD68-positive Cell Infiltration and Favorable Disease-free Survival in EGFR-mutant Lung Adenocarcinoma.Semantic proximity Read ↗

Targeting IL-1β as an immunopreventive and therapeutic modality for K-ras-mutant lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.